reglab/statecodes huggingface dataset:
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter E - STANDARDS FOR INPATIENT NONHOSPITAL ACTIVITIES-SHORT-TERM DETOXIFICATION › Section 711.66 - Medication control

Current through Register Vol. 54, No. 28, July 13, 2024
When the drug and alcohol project is not physically located
					 within the parent health care facility, it shall have a written policy
					 regarding medications used by clients which shall include, but not be limited
					 to:
(1) Administration of
				  medication.
(2) Drug storage
				  areas.
(3) Inspection of storage
				  areas.
(4) Methods for control and
				  accountability of drugs.
(5)
				  Security of drugs.
(6)
				  Inventories.
(7) Medication errors
				  and drug reactions.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter E - STANDARDS FOR INPATIENT NONHOSPITAL ACTIVITIES-SHORT-TERM DETOXIFICATION › Section 711.67 - Reserved

Current through Register Vol. 54, No. 28, July 13, 2024
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter F - STANDARDS FOR INPATIENT NONHOSPITAL ACTIVITIES-TRANSITIONAL LIVING FACILITIES (TLFs) › Section 711.71 - Intake and admission

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The project
				  director shall develop a written plan providing for intake and admission which
				  shall include, but not be limited to:
(1)
				  Criteria for admission.
(2)
				  Guidelines for completion of residency.
(3) Involuntary discharge/termination
				  criteria.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter F - STANDARDS FOR INPATIENT NONHOSPITAL ACTIVITIES-TRANSITIONAL LIVING FACILITIES (TLFs) › Section 711.72 - Client records

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
Record requirements.
There shall be a complete client record
				  on an individual which includes information relative to the client's
				  involvement with the project. In addition to the requirements in §
										115.32 (relating to contents), the
				  client record shall include the following:
(1) Drug and alcohol consent forms.
(2) Drug and alcohol referral
				  contact.
(3) Activity
				  notes.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter F - STANDARDS FOR INPATIENT NONHOSPITAL ACTIVITIES-TRANSITIONAL LIVING FACILITIES (TLFs) › Section 711.73 - Client management services

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
				  The project shall adopt a written plan for the coordination of residential
				  services which shall include, but not be limited to:
(1) Defined target population.
(2) Written procedures for the management of
				  residential services for clients.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter F - STANDARDS FOR INPATIENT NONHOSPITAL ACTIVITIES-TRANSITIONAL LIVING FACILITIES (TLFs) › Section 711.74 - Uniform Data Collection System

Current through Register Vol. 54, No. 28, July 13, 2024
(a) If a
				  project utilizes Department funds, it shall comply with the Department's
				  UDCS.
(b) A data collection system
				  shall be developed that allows for the efficient retrieval of data needed to
				  measure the project's performance.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter F - STANDARDS FOR INPATIENT NONHOSPITAL ACTIVITIES-TRANSITIONAL LIVING FACILITIES (TLFs) › Section 711.75 - Notification of termination

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The
				  project director shall notify the client, in writing, of a decision to
				  involuntarily terminate the client's treatment at the project. The notice shall
				  include the reason for termination.
(b) The client shall have an opportunity to
				  request reconsideration of a decision to terminate treatment.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter F - STANDARDS FOR INPATIENT NONHOSPITAL ACTIVITIES-TRANSITIONAL LIVING FACILITIES (TLFs) › Section 711.76 - Medication control

Current through Register Vol. 54, No. 28, July 13, 2024
When the drug and alcohol project is not physically located
					 within the parent health care facility, it shall have a written policy
					 regarding medications used by clients, which shall include, but not be limited
					 to:
(1) Administration of
				  medication.
(2) Drug storage
				  areas.
(3) Inspection of storage
				  areas.
(4) Methods for control and
				  accountability of drugs.
(5)
				  Security of drugs.
(6)
				  Inventories.
(7) Medication errors
				  and drug reactions.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter F - STANDARDS FOR INPATIENT NONHOSPITAL ACTIVITIES-TRANSITIONAL LIVING FACILITIES (TLFs) › Section 711.77 - Reserved

Current through Register Vol. 54, No. 28, July 13, 2024
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter G - STANDARDS FOR PARTIAL HOSPITALIZATION ACTIVITIES › Section 711.81 - Intake and admission

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The project
				  director shall develop a written plan providing for intake and admission which
				  shall include, but not be limited to:
(1)
				  Criteria for admission.
(2)
				  Treatment methodology.
(3)
				  Requirements for completion of treatment.
(4) Involuntary discharge/termination
				  criteria.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter G - STANDARDS FOR PARTIAL HOSPITALIZATION ACTIVITIES › Section 711.82 - Treatment and rehabilitation services

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The project shall adopt a written plan
				  for the coordination of client treatment and rehabilitation services which
				  includes, but is not limited to:
(1) Defined
				  target population.
(2) Treatment
				  models utilized by the project.
(3)
				  Written procedures for the development, approval and ongoing management of
				  treatment/rehabilitation services for clients.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter G - STANDARDS FOR PARTIAL HOSPITALIZATION ACTIVITIES › Section 711.83 - Client records

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
Record requirements.
There shall be a complete client record
				  on an individual which includes information relative to the client's
				  involvement with the project. In addition to the requirements in §
										115.32 (relating to contents), the
				  client record shall include the following:
(1) Drug and alcohol consent forms.
(2) Referral contact.
(3) Individualized drug and alcohol treatment
				  and rehabilitation plan.
(4)
				  Progress notes.
(5) Aftercare
				  plans, if applicable.
(6) Record of
				  services provided.
(7) Follow-up
				  information.
(8) Verification that
				  work done by the client at the project is an integral part of this treatment
				  and rehabilitation plan.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter G - STANDARDS FOR PARTIAL HOSPITALIZATION ACTIVITIES › Section 711.84 - Project management services

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
				  The partial hospitalization project shall operate at least 5 days of the week
				  and for a minimum of 40 hours per week. Additional hours should be appropriate
				  to the population served by the partial hospitalization project.
(b) The hours of project operation shall be
				  displayed conspicuously to the general public.
(c) A telephone number shall be displayed
				  conspicuously to the general public for emergency purposes.
(d) The project shall develop a written
				  aftercare policy.
(e) The project
				  shall develop a written follow-up policy.
(f) The project shall develop a written plan
				  providing for outreach services which shall include, but not be limited to:
(1) Identifying persons in need of project
				  services.
(2) Alerting persons and
				  their families to the availability of project services.
(3) Encouraging persons to utilize the
				  service delivery system.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter G - STANDARDS FOR PARTIAL HOSPITALIZATION ACTIVITIES › Section 711.85 - Uniform Data Collection System

Current through Register Vol. 54, No. 28, July 13, 2024
(a) If a
				  project utilizes Department funds, it shall comply with the Department's
				  UDCS.
(b) A data collection shall
				  be developed that allows for the efficient retrieval of data needed to measure
				  the project's performance.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter G - STANDARDS FOR PARTIAL HOSPITALIZATION ACTIVITIES › Section 711.86 - Notification of termination

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The
				  project director shall notify the client, in writing, of a decision to
				  involuntarily terminate the client's treatment at the project. The notice shall
				  include the reason for termination.
(b) The client shall have an opportunity to
				  request reconsideration of a decision to terminate treatment.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter G - STANDARDS FOR PARTIAL HOSPITALIZATION ACTIVITIES › Section 711.87 - Medication control

Current through Register Vol. 54, No. 28, July 13, 2024
When the drug and alcohol project is not physically located
					 within the parent health care facility, it shall have a written policy
					 regarding medications used by clients which includes, but is not limited
					 to:
(1) Administration of
				  medication.
(2) Drug storage
				  areas.
(3) Inspection of storage
				  areas.
(4) Methods for control and
				  accountability of drugs.
(5)
				  Security of drugs.
(6)
				  Inventories.
(7) Medication errors
				  and drug reactions.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter G - STANDARDS FOR PARTIAL HOSPITALIZATION ACTIVITIES › Section 711.88 - Reserved

Current through Register Vol. 54, No. 28, July 13, 2024
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter H - STANDARDS FOR OUTPATIENT ACTIVITIES › Section 711.91 - Intake and admission

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The project
				  director shall develop a written plan providing for intake and admission which
				  includes, but is not limited to:
(1) Criteria
				  for admission.
(2) Treatment
				  methodology.
(3) Requirements for
				  completion of treatment.
(4)
				  Involuntary discharge/termination criteria.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter H - STANDARDS FOR OUTPATIENT ACTIVITIES › Section 711.92 - Treatment and rehabilitation services

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The project shall adopt a written plan
				  for the coordination of client treatment and rehabilitation services which
				  includes, but is not limited to:
(1) Defined
				  target population.
(2) Treatment
				  models utilized by the project.
(3)
				  Written procedures for the development, approval and ongoing management of
				  treatment/rehabilitation services for clients.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter H - STANDARDS FOR OUTPATIENT ACTIVITIES › Section 711.93 - Client records

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
Record requirements.
There shall be a complete client record
				  on an individual which includes information relative to the client's
				  involvement with the project. In addition to the requirements in §
										115.32 (relating to contents), the
				  client record shall include the following:
(1) Drug and alcohol consent forms.
(2) Record of services provided.
(3) Referral contact.
(4) Progress notes.
(5) Individualized drug and alcohol treatment
				  and rehabilitation plan.
(6)
				  Aftercare plans, if applicable.
(7)
				  Follow-up information.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter H - STANDARDS FOR OUTPATIENT ACTIVITIES › Section 711.94 - Project management services

Current through Register Vol. 54, No. 28, July 13, 2024
(a)
				  Outpatient projects shall make an effort to adjust the hours of project
				  operations to meet client needs, taking into account other client time
				  commitments such as employment and school schedules.
(b) The hours of project operation shall be
				  displayed conspicuously to the general public.
(c) A telephone number shall be displayed
				  conspicuously to the general public for emergency purposes.
(d) The project shall develop a written
				  client aftercare policy.
(e) The
				  project shall develop a written client follow-up policy.
(f) The project shall develop a written plan
				  providing for outreach services which include, but not be limited to:
(1) Identifying persons in need of project
				  services.
(2) Alerting persons and
				  their families to the availability of project services.
(3) Encouraging persons to utilize the
				  service delivery system.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter H - STANDARDS FOR OUTPATIENT ACTIVITIES › Section 711.95 - Uniform Data Collection System

Current through Register Vol. 54, No. 28, July 13, 2024
(a) If a
				  project utilizes Department funds, it shall comply with the Department's
				  UDCS.
(b) A data collection system
				  shall be developed that allows for the efficient retrieval of data needed to
				  measure the project's performance.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter H - STANDARDS FOR OUTPATIENT ACTIVITIES › Section 711.96 - Notification of termination

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The
				  project director shall notify the client, in writing, of a decision to
				  involuntarily terminate the client's treatment at the project. The notice shall
				  include the reason for termination.
(b) The client shall have the opportunity to
				  request reconsideration of a decision terminating treatment.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter H - STANDARDS FOR OUTPATIENT ACTIVITIES › Section 711.97 - Medication control

Current through Register Vol. 54, No. 28, July 13, 2024
When the drug and alcohol project is not physically located
					 within the parent health care facility, it shall have a written policy
					 regarding all medications used by clients which includes, but is not limited
					 to:
(1) Administration of
				  medication.
(2) Drug storage
				  areas.
(3) Inspection of storage
				  areas.
(4) Methods for control and
				  accountability of drugs.
(5)
				  Security of drugs.
(6)
				  Inventories.
(7) Medication errors
				  and drug reactions.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 711 - STANDARDS FOR CERTIFICATION OF TREATMENT ACTIVITIES WHICH ARE A PART OF A HEALTH CARE FACILITY › Subchapter H - STANDARDS FOR OUTPATIENT ACTIVITIES › Section 711.98 - Physical plant

Current through Register Vol. 54, No. 28, July 13, 2024
When the project is not physically located within a health
					 care facility, it shall be site visited annually for the following
					 requirements:
(1) Counseling
				  areas.
(2) Office space.
(3) Lavatories.
(4) Fire escape/emergency exits.
(5) Fire extinguishers.
(6) General maintenance.
(7) Certificate of Occupancy from the
				  Department of Labor and Industry or its equivalent.
(8) Compliance with applicable local
				  ordinances and regulations.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.1 - General provisions

Current through Register Vol. 54, No. 28, July 13, 2024
(a) An
				entity within this Commonwealth which uses agents for maintenance or
				detoxification of persons shall obtain the approval of the Department to
				operate a narcotic treatment program.
(b) The Department's approval of a narcotic
				treatment program shall be contingent upon the narcotic treatment program's
				compliance with the standards and conditions in this part. In addition, the
				program shall comply with applicable Federal laws and regulations.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.2 - Relationship of Federal and State regulations

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A narcotic treatment program shall comply
				with Federal regulations and requirements governing the administration,
				dispensing and storage of agents.
(b) This chapter is intended to supplement
				the Federal regulations governing narcotic treatment programs in 21 CFR Chapter
				II, 1300-1399 (relating to Drug Enforcement Administration, Department of
				Justice).
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.3 - Approval of narcotic treatment programs

Current through Register Vol. 54, No. 28, July 13, 2024
(a) An entity shall apply for and receive
				approval as required from the Department, DEA and CSAT or an organization
				designated by the Substance Abuse and Mental Health Services Administration
				(SAMHSA), under the authority of section 303 of the Controlled Substances Act
				(21 U.S.C.A. §
										823) and sections 501(d), 509(a), 543, 1923,
				1927(a) and 1976 of the Public Health Service Act (42 U.S.C.A. §§
										290aa(d),
				290bb-2(a),
				290dd-2,
				300x-23,
				300x-27(a) and
				300y-11), prior to
				offering services within this Commonwealth as a narcotic treatment program.
				Application for approval shall be made simultaneously to the Department, DEA
				and CSAT or SAMHSA designee.
(1) The
				Department will forward a recommendation for approval to the Federal officials
				after a review of policies and procedures and an onsite inspection by an
				authorized representative of the Department and after a determination has been
				made that the requirements for approval under this chapter have been
				met.
(2) The decision of the
				Federal officials set forth in 21 CFR Chapter II (relating to Drug Enforcement
				Administration, Department of Justice) or other Federal statutes shall
				constitute the final determination on the application for approval by DEA and
				CSAT or SAMHSA designee.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.4 - Denial, revocation or suspension of approval

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The Department will deny, suspend or
				revoke approval of a narcotic treatment program if the applicant or program
				fails to comply with this chapter. Procedures for the revocation, suspension or
				denial of Department approval, and appeals from these actions, shall be the
				same as procedures in §§ 709.17, 709.18, 711.17 and 711.18.
(b) The Department may recommend to the DEA
				or CSAT or SAMHSA's designee to initiate proceedings to revoke or deny Federal
				approval.
(c) The Department may
				seek an injunction for the closure of a narcotic treatment program in a court
				of competent jurisdiction.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.5 - Patient capacity

Current through Register Vol. 54, No. 28, July 13, 2024
The Department may increase or decrease the number of
				  patients a narcotic treatment program may treat. The Department may raise the
				  patient capacity, upon the written request of the narcotic treatment program,
				  based upon the Department's review of the narcotic treatment program. The
				  factors the Department will consider include:
(1)
Safety.
Considerations
				include dispensing time, internal patient flow and external traffic
				patterns.
(2)
Physical
				facility.
Considerations include the number and size of counseling
				offices, waiting areas, restrooms, and dispensing and nursing
				windows.
(3)
Staff size and
				composition.
Considerations include the number of narcotic treatment
				physicians, dispensing and counseling staff.
(4)
Ability to provide required
				services.
Considerations include compliance with licensing and
				narcotic treatment program regulations as determined during licensing,
				monitoring and special visits to the narcotic treatment program.
(5)
Availability and accessibility of
				service.
Considerations include the location of the narcotic treatment
				program and the hours of operation.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.6 - Physician staffing

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A narcotic
				treatment program shall designate a medical director to assume responsibility
				for administering all medical services performed by the narcotic treatment
				program.
(1) A medical director shall be a
				physician and shall have obtained one of the following:
(i) Three years documented experience in the
				provision of services to persons who are addicted to alcohol or other drugs,
				including at least 1 year of experience in the treatment of narcotic addiction
				with a narcotic drug.
(ii)
				Certification in addiction medicine by the American Society of Addiction
				Medicine.
(iii) A certificate of
				added qualifications in addiction psychiatry by the American Board of
				Psychiatry and Neurology, Inc.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.7 - Dispensing or administering staffing

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A narcotic treatment program shall be
				staffed as follows:
(1) If it operates an
				automated dispensing system, one full-time nurse or other person authorized by
				law to administer or dispense a controlled substance shall be available for
				every 200 patients.
(2) If it
				operates a manual or nonautomatic dispensing system, one full-time nurse or
				other person authorized by law to administer or dispense a controlled substance
				shall be available for every 150 patients.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.8 - Psychosocial staffing

Current through Register Vol. 54, No. 28, July 13, 2024
A narcotic treatment program shall comply with the following
				  staffing ratios as established in Chapter 704 (relating to staffing
				  requirements for drug and alcohol treatment activities.):
(1)
General requirements.
A
				narcotic treatment program shall comply with the patient/staff and
				patient/counselor ratios in subparagraphs (i)-(vi) during primary care hours.
				These ratios refer to the total number of patients being treated, including
				patients with diagnoses other than drug and alcohol addiction served in other
				facets of the project. Family units may be counted as one patient.
(i)
Inpatient nonhospital
				detoxification (residential detoxification).
(A) There shall be one full-time equivalent
				(FTE) primary care staff person available for every seven patients during
				primary care hours.
(B) There shall
				be a narcotic treatment physician on-call at all times.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.9 - Intake

Current through Register Vol. 54, No. 28, July 13, 2024
(a) Prior to
				administration of an agent, a narcotic treatment program shall screen each
				individual to determine eligibility for admission. The narcotic treatment
				program shall:
(1) Verify that the individual
				has reached 18 years of age.
(2)
				Verify the individual's identity, including name, address, date of birth,
				emergency contact and other identifying data.
(3) Obtain a drug use history and current
				drug use status of the individual.
(4) Have a narcotic treatment physician make
				a face-to-face determination of whether an individual is currently
				physiologically dependent upon a narcotic drug and has been physiologically
				dependent for at least 1 year prior to admission for maintenance treatment. The
				narcotic treatment physician shall document in the patient's record the basis
				for the determination of current dependency and evidence of a 1 year history of
				addiction.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.10 - Pregnant patients

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A narcotic
				treatment program may place a pregnant patient, regardless of age, who has had
				a documented narcotic dependency in the past and who may return to narcotic
				dependency, on a comprehensive maintenance regime.
(1) For these patients, evidence of current
				physiological dependence on narcotic drugs is not needed if a narcotic
				treatment physician certifies the pregnancy and, exercising reasonable clinical
				judgment, finds treatment to be medically justified.
(2) Evidence of all findings and the criteria
				used to determine the findings shall be recorded in the patient's record by the
				admitting narcotic treatment physician before the initial dose is administered
				to the patient.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.11 - Confidentiality of patient records

Current through Register Vol. 54, No. 28, July 13, 2024
A narcotic treatment program shall physically secure and
				  maintain the confidentiality of all patient records in accordance with
				  42 CFR
				  2.22 (relating to notice to patients of
				  Federal confidentiality requirements) and §
									709.28 (relating to
				  confidentiality).
This section cited in 28 Pa. Code §
											715.20 (relating to patient
					 transfers).
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.12 - Informed patient consent

Current through Register Vol. 54, No. 28, July 13, 2024
A narcotic treatment program shall obtain an informed,
				  voluntary, written consent before an agent may be administered to the patient
				  for either maintenance or detoxification treatment. The following shall appear
				  on the patient consent form:
(1) That
				methadone and LAAM are narcotic drugs which can be harmful if taken without
				medical supervision.
(2) That
				methadone and LAAM are addictive medications and may, like other drugs used in
				medical practices, produce adverse results.
(3) That alternative methods of treatment
				exist.
(4) That the possible risks
				and complications of treatment have been explained to the patient.
(5) That methadone is transmitted to the
				unborn child and will cause physical dependence.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.13 - Patient identification

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A
				narcotic treatment program shall use a system for patient identification for
				the purpose of verifying the correct identity of a patient prior to
				administration of an agent.
(b) A
				narcotic treatment program shall maintain onsite a photograph of each patient
				which includes the patient's name and birth date. The narcotic treatment
				program shall update the photograph every 3 years.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.14 - Urine testing

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A narcotic
				treatment program shall complete an initial drug-screening urinalysis for each
				prospective patient and a random urinalysis at least monthly thereafter.
(1) Each test shall be for opiates,
				methadone, amphetamines, barbiturates, cocaine and benzodiazepines.
(2) If the narcotic treatment program
				determines that other drugs are abused in that narcotic treatment program's
				locality or have been identified in the patient's drug and alcohol history as
				being a drug of abuse or use, a narcotic treatment program may conduct a test
				or analysis for other drugs as well.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.15 - Medication dosage

Current through Register Vol. 54, No. 28, July 13, 2024
(a) The narcotic
				treatment physician shall review the dosage levels at least twice a year, with
				each review occurring at least 2 months apart, to determine a patient's
				therapeutic dosage.
(b) The
				narcotic treatment physician shall determine the proper dosage level for a
				patient, except as otherwise provided in this section. If the narcotic
				treatment physician determining the initial dose is not the narcotic treatment
				physician who conducted the patient examination, the narcotic treatment
				physician shall consult with the narcotic treatment physician who performed the
				examination before determining the patient's initial dose and
				schedule.
(c) Methadone shall be
				administered or dispensed only in oral form and shall be formulated to reduce
				its potential for parenteral abuse.
(d) A narcotic treatment program shall label
				all take-home medication with the patient's name and the narcotic treatment
				program's name, address and telephone number and shall package all take-home
				medication as required by Federal regulation.
(e) LAAM shall be administered or dispensed
				only in oral form and shall be formulated to reduce its potential for
				parenteral abuse.
(f) The narcotic
				treatment program shall develop written policies and procedures relating to
				narcotic treatment medication dosage which includes the requirements of
				subsections (a)-(e).
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.16 - Take-home privileges

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A
				narcotic treatment program shall determine whether a patient may be provided
				take-home medications.
(1) A narcotic
				treatment program may give take-home medications only to a patient who the
				narcotic treatment physician has determined is responsible and able to handle
				narcotic drugs outside the narcotic treatment program.
(2) The narcotic treatment physician shall
				make this determination after consultations with staff involved in the
				patient's care.
(3) The narcotic
				treatment physician shall document in the patient record the rationale for
				permitting take-home medication.
(4) A narcotic treatment physician may
				rescind take-home medication privileges.
(5) A narcotic treatment program shall
				develop written policies and procedures relating to granting and rescinding
				take-home medication privileges.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.17 - Medication control

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A narcotic
				treatment program shall comply with applicable Federal and State statutes and
				regulations regarding the storing, compounding, administering and dispensing of
				medication.
(b) A narcotic
				treatment program shall develop policies and procedures regarding verbal
				medication orders, including the issuing and receiving of orders, identifying
				circumstances when orders are appropriate and documenting orders, in accordance
				with applicable Federal and State statutes and regulations.
(c) A narcotic treatment program shall
				develop and implement written policies and procedures regarding the medications
				used by patients which shall include, at a minimum:
(1)
Administration of
				medication.
(i) A narcotic treatment
				physician shall determine the patient's initial and subsequent dose and
				schedule. The physician shall communicate the initial and subsequent dose and
				schedule to the person responsible for the administration of medication. Each
				medication order and dosage change shall be written and signed by the narcotic
				treatment physician.
(ii) An agent
				shall be administered or dispensed only by a practitioner licensed under the
				appropriate Federal and State laws to dispense agents to patients.
(iii) Only authorized staff and patients who
				are receiving medication shall be permitted in the dispensing area.
(iv) There shall be only one patient
				permitted at a dispensing station at any given time.
(v) Each patient shall be observed when
				ingesting the agent.
(vi)
				Administering and dispensing shall be conducted in a manner that protects the
				patient from disruption or annoyance from other individuals.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.18 - Rehabilitative services

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A narcotic
				treatment program shall provide, either onsite or through referral agreements,
				a full range of rehabilitative services. Rehabilitative services shall include:
(1) HIV education services.
(2) Employment services.
(3) Adult educational services.
(4) Behavioral health services.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.19 - Psychotherapy services

Current through Register Vol. 54, No. 28, July 13, 2024
A narcotic treatment program shall provide individualized
				  psychotherapy services and shall meet the following requirements:
(1) A narcotic treatment program shall
				provide each patient an average of 2.5 hours of psychotherapy per month during
				the patient's first 2 years, 1 hour of which shall be individual psychotherapy.
				Additional psychotherapy shall be provided as dictated by ongoing assessment of
				the patient.
(2) A narcotic
				treatment program shall provide each patient at least 1 hour per month of group
				or individual psychotherapy during the third and fourth year of treatment.
				Additional psychotherapy shall be provided as dictated by ongoing assessment of
				the patient.
(3) After 4 years of
				treatment, a narcotic treatment program shall provide each patient with at
				least 1 hour of group or individual psychotherapy every 2 months. Additional
				psychotherapy shall be provided as dictated by ongoing assessment of the
				patient.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.20 - Patient transfers

Current through Register Vol. 54, No. 28, July 13, 2024
A narcotic treatment program shall develop written transfer
				  policies and procedures which shall require that the narcotic treatment program
				  transfer a patient to another narcotic treatment program for continued
				  maintenance, detoxification or another treatment activity within 7 days of the
				  request of the patient.
(1) The
				transferring narcotic treatment program shall transfer patient files which
				include admission date, medical and psychosocial summaries, dosage level,
				urinalysis reports or summary, exception requests, and current status of the
				patient, and shall contain the written consent of the patient.
(2) A narcotic treatment program shall
				maintain the confidentiality of patient records remaining in its possession
				after the transfer under §
									715.11 (relating to
				confidentiality of patient records).
(3) The transferring narcotic treatment
				program shall document what materials were sent to the receiving narcotic
				treatment program.
(4) The
				receiving narcotic treatment program shall document in writing that it notified
				the transferring narcotic treatment program of the admission of the patient and
				the date of the initial dose given to the patient by the receiving narcotic
				treatment program.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.21 - Patient termination

Current through Register Vol. 54, No. 28, July 13, 2024
A narcotic treatment program shall develop and implement
				  policies and procedures regarding involuntary terminations. Involuntary
				  terminations shall be initiated only when all other efforts to retain the
				  patient in the program have failed.
(1) A narcotic treatment program may
				involuntarily terminate a patient from the narcotic treatment program if it
				deems that the termination would be in the best interests of the health or
				safety of the patient and others, or the program finds any of the following
				conditions to exist:
(i) The patient has
				committed or threatened to commit acts of physical violence in or around the
				narcotic treatment program premises.
(ii) The patient possessed a controlled
				substance without a prescription or sold or distributed a controlled substance,
				in or around the narcotic treatment program premises.
(iii) The patient has been absent from the
				narcotic treatment program for 3 consecutive days or longer without
				cause.
(iv) The patient has failed
				to follow treatment plan objectives.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.22 - Patient grievance procedures

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A
				narcotic treatment program shall develop and utilize a patient grievance
				procedure.
(b) The procedure shall
				permit aggrieved patients a full and fair opportunity to be heard, to question
				and confront persons and evidence used against them and to have a fair review
				of their grievances by the narcotic treatment program director. If the
				grievance is filed against the narcotic treatment program director, the review
				of the case shall be conducted by either a multi-representative group of the
				narcotic treatment program or a subcommittee of the governing body instituted
				for the express purposes of grievance adjudication.
(c) Penalties may not be initiated prior to
				final resolution with the exception that penalties may be initiated against
				patients who have committed acts of physical violence or who have threatened to
				commit acts of physical violence in or around the narcotic treatment program
				premises.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.23 - Patient records

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A narcotic
				treatment program shall maintain patient records in conformance with
				42 CFR
				2.16 and
				2.22 (relating to security for
				written records; and notice to patients of Federal confidentiality
				requirements) and State statutes and regulations. A narcotic treatment program
				shall maintain a complete file on the premises for each present and former
				patient of the narcotic treatment program for at least 4 years after the
				patient has completed treatment or treatment has been terminated. Files shall
				be updated regularly so that the information is current.
(b) Each patient file shall include the
				following information:
(1) A complete personal
				history.
(2) A complete drug and
				alcohol history.
(3) A complete
				medical history.
(4) The results of
				an initial intake physical examination.
(5) The results of all annual physical
				examinations given by the narcotic treatment program which includes an annual
				reevaluation by the narcotic treatment physician.
(6) Results of laboratory tests or other
				special examinations given by the narcotic treatment program.
(7) Documentation of a 1-year history of
				narcotic dependency, if applicable.
(8) The patient's current and past narcotic
				dosage level.
(9) Other drugs
				prescribed by the narcotic treatment physician and the reasons
				therefore.
(10) Urine testing
				results.
(11) Counselor notes
				regarding patient progress and status.
(12) Applicable consent forms.
(13) Patient record of services.
(14) Case consultation notes regarding the
				patient.
(15) Psychosocial
				evaluations of the patient.
(16)
				Any psychiatric, psychological or other evaluations, if available.
(17) Treatment plans and applicable periodic
				treatment plan updates.
(18)
				Federal and State exceptions to the regulations granted to the project on
				behalf of the patient.
(19)
				Referrals to other projects or services.
(20) Take-home privileges granted to the
				patient.
(21) Annual evaluation by
				the counselor.
(22) Aftercare plan,
				if applicable.
(23) Discharge
				summary.
(24) Follow-up information
				regarding the patient.
(25)
				Documentation of patient grievances.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.24 - Narcotic detoxification

Current through Register Vol. 54, No. 28, July 13, 2024
If a narcotic treatment program provides narcotic
				  detoxification services, the narcotic treatment program shall develop and
				  implement narcotic detoxification policies and procedures which include the
				  following:
(1) For narcotic
				detoxification from methadone or any other narcotic, the detoxification service
				may not exceed 180 days.
(2) For
				calculating the 1-year narcotic dependency history required for admission to
				maintenance treatment, the narcotic detoxification period may not be
				included.
(3) A 1-year physiologic
				dependence is not required for narcotic detoxification although documentation
				of current dependency is required.
(4) Minimum requirements for short-term
				narcotic detoxification treatment are as follows:
(i) Take-home medication is not allowed
				during a 30-day narcotic detoxification treatment. A narcotic treatment program
				shall observe the patient ingesting the medication 7 days per week.
(ii) The narcotic treatment program shall
				perform an initial drug screening test or analysis.
(iii) The narcotic treatment program shall
				develop a treatment plan. The patient's counselor shall monitor the patient's
				progress toward the goal of short-term narcotic detoxification and possible
				drug-free treatment referral.
(iv)
				No narcotic treatment program may provide short-term narcotic detoxification
				treatment to an individual until at least 7 days after the conclusion of any
				previous short-term narcotic detoxification treatment.
Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part V - Department of Drug and Alcohol Programs › Chapter 715 - STANDARDS FOR APPROVAL OF NARCOTIC TREATMENT PROGRAM › Section 715.26 - Security

Current through Register Vol. 54, No. 28, July 13, 2024
(a) A narcotic
				treatment program shall meet the security standards for the distribution and
				storage of controlled substances as required by Federal regulations, including
				21 CFR
				1301.72 and
				1301.74 (relating to physical
				security controls; and other security controls) and State statutes and
				regulations.
(b) Each narcotic
				treatment program shall provide the Department with a specific plan describing
				the efforts it will make to avoid disruption of the community by its patients
				and the actions it will take to assure responsiveness to the community. This
				plan shall designate a staff member to act as community liaison.